Drugs / Carboplatino
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02371161 | Feb 2014 → Dec 2018 | non-Hodgkin lymphoma | Fondazione Italiana Linfomi - ETS | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Carboplatino | “* Carboplatino AUC=5, e.v. (max 800 mg/mq), day 2 (if ≥70 years AUC=4)” NCT02371161 ↗ |
| Route | Intravenous | “Carboplatino AUC=5, e.v.” NCT02371161 ↗ |